What is NDC 70771-1550?

70771-1550 is the product NDC for betamethasone dipropionate, Betamethasone dipropionate .5 mg/g ointment, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for betamethasone dipropionate?

53 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

betamethasone dipropionate NDC 70771-1550

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1550Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1550Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1550-1	7077115500170771155001	1 TUBE in 1 CARTON (70771-1550-1) / 15 g in 1 TUBEMarketed from Jul 20, 2020
70771-1550-4	7077115500470771155004	1 TUBE in 1 CARTON (70771-1550-4) / 45 g in 1 TUBEMarketed from Jul 20, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): betamethasone dipropionate
Generic name (nonproprietary): betamethasone dipropionate
Active ingredients: Betamethasone dipropionate — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214048
Marketing start: Jul 20, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70771-1550_34685b34-d41c-4a8b-b6db-9cd17e4ced70SPL ID 34685b34-d41c-4a8b-b6db-9cd17e4ced70SPL set ID f531da27-2435-49a3-8992-c65240c6a7feRxCUI 197405UNII 826Y60901U
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771155001 followed by a unit qualifier and the quantity

Package 70771-1550-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 5, 2022.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1550

What is NDC 70771-1550?: 70771-1550 is the product NDC for betamethasone dipropionate, Betamethasone dipropionate .5 mg/g ointment, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: betamethasone dipropionate.
What is the active ingredient?: Betamethasone dipropionate.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for betamethasone dipropionate?: 53 other product NDCs are listed under this name. See all betamethasone dipropionate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other betamethasone dipropionate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	CreamTopical	Aurobindo Pharma Limited	59651-891	59651-0891-1459651-0891-46
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/mL	Lotion, AugmentedTopical	Encube Ethicals, Inc.	21922-104	21922-0104-0121922-0104-21
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	Ointment, AugmentedTopical	Burel Pharmaceuticals, LLC	35573-107	35573-0107-1535573-0107-49
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	CreamTopical	REMEDYREPACK INC.	70518-4187	70518-4187-00
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	Ointment, AugmentedTopical	Aurobindo Pharma Limited	59651-699	59651-0699-1459651-0699-4659651-0699-50
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-9323	63629-9323-01
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-9324	63629-9324-01
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	OintmentTopical	Padagis Israel Pharmaceuticals Ltd	45802-505	45802-0505-1445802-0505-84
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	OintmentTopical	Bryant Ranch Prepack	71335-2715	71335-2715-01
Betamethasone Dipropionate	Betamethasone dipropionate .5 mg/g	OintmentTopical	Bryant Ranch Prepack	72162-1415	72162-1415-0272162-1415-04

All 54 betamethasone dipropionate NDCs

Other NDCs under ANDA 214048

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214048
Product	Strength	Form · route	Labeler	Product NDC
betamethasone dipropionate	Betamethasone dipropionate .5 mg/g	OintmentTopical	Viona Pharmaceuticals Inc	72578-093